UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000050502 |
|---|---|
| Receipt number | R000057502 |
| Scientific Title | Systematic review of pediatric care in pharmaceutical intervention |
| Date of disclosure of the study information | 2023/03/06 |
| Last modified on | 2023/09/26 11:59:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Select training items of pediatric care in pharmaceutical intervention
Acronym
Select training items of pediatric care in pharmaceutical intervention
Scientific Title
Systematic review of pediatric care in pharmaceutical intervention
Scientific Title:Acronym
Systematic review of pediatric care in pharmaceutical intervention
Region
| Japan |
Condition
Condition
Pediatric disease
Classification by specialty
| Pediatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Select training items of pediatric care in pharmaceutical intervention.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Select training items of pediatric care in pharmaceutical intervention.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Database: PubMed, Ichushi-Web
2. Clinical Trial
3. Intervention of pharmacists
4. Patients endpoint
# Do to not only pediatric study but all study
5. Keywords: Pharmasicts AND (Tracheostomy OR Ventilators, Mechanical OR Suction OR Oxygen Inhalation Therapy OR Gastric fistula OR Intestinal Fistula OR Enteral Nutrition OR Parenteral Nutrition, Total OR Home Care Services)
Key exclusion criteria
1. Articles limited to non-pediatrics
2. Disorders less relevant to children
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Hisashi |
| Middle name | |
| Last name | IIJIMA |
Organization
Chiba Pharmaceutical Association
Division name
Drug Information Center
Zip code
260-0025
Address
9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba, Japan
TEL
043-247-4401
h-iijima@c-yaku.or.jp
Public contact
Name of contact person
| 1st name | Hisashi |
| Middle name | |
| Last name | IIJIMA |
Organization
Chiba Pharmaceutical Association
Division name
Drug Information Center
Zip code
260-0025
Address
9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba, Japan
TEL
043-247-4401
Homepage URL
h-iijima@c-yaku.or.jp
Sponsor or person
Institute
Chiba Pharmaceutical Association
Institute
Department
Personal name
Funding Source
Organization
Japan Pharmaceutical Association
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Not applicable
Address
Not applicable
Tel
Not applicable
Not applicable
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 03 | Month | 06 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
1682
Results
Extracted papers (38 articles)
Impact of pharmacist intervention are as follows.
Medication review, Nutritional control, Monitoring, Management program, Home-visiting, Collaborative care, Telemedicine, Medical cooperation, Prescription suggestion, Consultation, Patient education, Independent prescription, Home management of patients
Analysis papers (4 articles, n=1682)
The pharmacist's intervention resulted in a decrease in SBP by 5.87 mmHg (95%CI 3.41-8.32), and DBP by 2.72mmHg (1.13-4.32).
Results date posted
| 2023 | Year | 09 | Month | 26 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Not applicable
Participant flow
Not applicable
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2023 | Year | 03 | Month | 01 | Day |
Date of IRB
| 2023 | Year | 03 | Month | 01 | Day |
Anticipated trial start date
| 2023 | Year | 03 | Month | 06 | Day |
Last follow-up date
| 2023 | Year | 05 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
1. Database: PubMed, Ichushi-Web
2. Clinical Trial
3. Intervention of pharmacists
4. Patients endpoint
# Do to not only pediatric study but all study
5. Keywords: Pharmasicts AND (Tracheostomy OR Ventilators, Mechanical OR Suction OR Oxygen Inhalation Therapy OR Gastric fistula OR Intestinal Fistula OR Enteral Nutrition OR Parenteral Nutrition, Total OR Home Care Services)
Management information
Registered date
| 2023 | Year | 03 | Month | 06 | Day |
Last modified on
| 2023 | Year | 09 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057502
